Global Antisense Oligonucleotides (ASO) Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 138

Published Date: 03 Jan 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASO) Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Antisense oligonucleotide (ASO) drugs are small, synthetic single-stranded nucleic acid polymers that can be used to regulate gene expression through a variety of mechanisms.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Antisense Oligonucleotides (ASO) Drug industry chain, the market status of Single Gene Rare Disease (Fomivirsen, Spinraza), Protein Deposition Disease (Fomivirsen, Spinraza), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antisense Oligonucleotides (ASO) Drug.

Regionally, the report analyzes the Antisense Oligonucleotides (ASO) Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antisense Oligonucleotides (ASO) Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Antisense Oligonucleotides (ASO) Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antisense Oligonucleotides (ASO) Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Fomivirsen, Spinraza).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antisense Oligonucleotides (ASO) Drug market.

Regional Analysis: The report involves examining the Antisense Oligonucleotides (ASO) Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antisense Oligonucleotides (ASO) Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Antisense Oligonucleotides (ASO) Drug:
Company Analysis: Report covers individual Antisense Oligonucleotides (ASO) Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antisense Oligonucleotides (ASO) Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Single Gene Rare Disease, Protein Deposition Disease).

Technology Analysis: Report covers specific technologies relevant to Antisense Oligonucleotides (ASO) Drug. It assesses the current state, advancements, and potential future developments in Antisense Oligonucleotides (ASO) Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antisense Oligonucleotides (ASO) Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Antisense Oligonucleotides (ASO) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Fomivirsen
Spinraza
Tegsedi
Waylivra
Vyondys 53

Market segment by Application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others

Major players covered
Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Alnylam

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antisense Oligonucleotides (ASO) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antisense Oligonucleotides (ASO) Drug, with price, sales, revenue and global market share of Antisense Oligonucleotides (ASO) Drug from 2019 to 2024.
Chapter 3, the Antisense Oligonucleotides (ASO) Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antisense Oligonucleotides (ASO) Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antisense Oligonucleotides (ASO) Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antisense Oligonucleotides (ASO) Drug.
Chapter 14 and 15, to describe Antisense Oligonucleotides (ASO) Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Antisense Oligonucleotides (ASO) Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Fomivirsen
        1.3.3 Spinraza
        1.3.4 Tegsedi
        1.3.5 Waylivra
        1.3.6 Vyondys 53
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Single Gene Rare Disease
        1.4.3 Protein Deposition Disease
        1.4.4 Chronic Liver Disease
        1.4.5 Others
    1.5 Global Antisense Oligonucleotides (ASO) Drug Market Size & Forecast
        1.5.1 Global Antisense Oligonucleotides (ASO) Drug Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Antisense Oligonucleotides (ASO) Drug Sales Quantity (2019-2030)
        1.5.3 Global Antisense Oligonucleotides (ASO) Drug Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Ionis
        2.1.1 Ionis Details
        2.1.2 Ionis Major Business
        2.1.3 Ionis Antisense Oligonucleotides (ASO) Drug Product and Services
        2.1.4 Ionis Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Ionis Recent Developments/Updates
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Antisense Oligonucleotides (ASO) Drug Product and Services
        2.2.4 Novartis Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Novartis Recent Developments/Updates
    2.3 Biogen
        2.3.1 Biogen Details
        2.3.2 Biogen Major Business
        2.3.3 Biogen Antisense Oligonucleotides (ASO) Drug Product and Services
        2.3.4 Biogen Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Biogen Recent Developments/Updates
    2.4 Akcea
        2.4.1 Akcea Details
        2.4.2 Akcea Major Business
        2.4.3 Akcea Antisense Oligonucleotides (ASO) Drug Product and Services
        2.4.4 Akcea Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Akcea Recent Developments/Updates
    2.5 Therapeutics
        2.5.1 Therapeutics Details
        2.5.2 Therapeutics Major Business
        2.5.3 Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
        2.5.4 Therapeutics Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Therapeutics Recent Developments/Updates
    2.6 Sarepta Therapeutics
        2.6.1 Sarepta Therapeutics Details
        2.6.2 Sarepta Therapeutics Major Business
        2.6.3 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
        2.6.4 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Sarepta Therapeutics Recent Developments/Updates
    2.7 WAVElife
        2.7.1 WAVElife Details
        2.7.2 WAVElife Major Business
        2.7.3 WAVElife Antisense Oligonucleotides (ASO) Drug Product and Services
        2.7.4 WAVElife Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 WAVElife Recent Developments/Updates
    2.8 ProQR
        2.8.1 ProQR Details
        2.8.2 ProQR Major Business
        2.8.3 ProQR Antisense Oligonucleotides (ASO) Drug Product and Services
        2.8.4 ProQR Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 ProQR Recent Developments/Updates
    2.9 Exicure
        2.9.1 Exicure Details
        2.9.2 Exicure Major Business
        2.9.3 Exicure Antisense Oligonucleotides (ASO) Drug Product and Services
        2.9.4 Exicure Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Exicure Recent Developments/Updates
    2.10 Secarna
        2.10.1 Secarna Details
        2.10.2 Secarna Major Business
        2.10.3 Secarna Antisense Oligonucleotides (ASO) Drug Product and Services
        2.10.4 Secarna Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Secarna Recent Developments/Updates
    2.11 AstraZeneca
        2.11.1 AstraZeneca Details
        2.11.2 AstraZeneca Major Business
        2.11.3 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product and Services
        2.11.4 AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 AstraZeneca Recent Developments/Updates
    2.12 The WhiteOak Group, Inc.
        2.12.1 The WhiteOak Group, Inc. Details
        2.12.2 The WhiteOak Group, Inc. Major Business
        2.12.3 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product and Services
        2.12.4 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 The WhiteOak Group, Inc. Recent Developments/Updates
    2.13 Dicerna
        2.13.1 Dicerna Details
        2.13.2 Dicerna Major Business
        2.13.3 Dicerna Antisense Oligonucleotides (ASO) Drug Product and Services
        2.13.4 Dicerna Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Dicerna Recent Developments/Updates
    2.14 Silence
        2.14.1 Silence Details
        2.14.2 Silence Major Business
        2.14.3 Silence Antisense Oligonucleotides (ASO) Drug Product and Services
        2.14.4 Silence Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Silence Recent Developments/Updates
    2.15 Arrowhead
        2.15.1 Arrowhead Details
        2.15.2 Arrowhead Major Business
        2.15.3 Arrowhead Antisense Oligonucleotides (ASO) Drug Product and Services
        2.15.4 Arrowhead Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Arrowhead Recent Developments/Updates
    2.16 Alnylam
        2.16.1 Alnylam Details
        2.16.2 Alnylam Major Business
        2.16.3 Alnylam Antisense Oligonucleotides (ASO) Drug Product and Services
        2.16.4 Alnylam Antisense Oligonucleotides (ASO) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Alnylam Recent Developments/Updates

3 Competitive Environment: Antisense Oligonucleotides (ASO) Drug by Manufacturer
    3.1 Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Antisense Oligonucleotides (ASO) Drug Revenue by Manufacturer (2019-2024)
    3.3 Global Antisense Oligonucleotides (ASO) Drug Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Antisense Oligonucleotides (ASO) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Antisense Oligonucleotides (ASO) Drug Manufacturer Market Share in 2023
        3.4.2 Top 6 Antisense Oligonucleotides (ASO) Drug Manufacturer Market Share in 2023
    3.5 Antisense Oligonucleotides (ASO) Drug Market: Overall Company Footprint Analysis
        3.5.1 Antisense Oligonucleotides (ASO) Drug Market: Region Footprint
        3.5.2 Antisense Oligonucleotides (ASO) Drug Market: Company Product Type Footprint
        3.5.3 Antisense Oligonucleotides (ASO) Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Antisense Oligonucleotides (ASO) Drug Market Size by Region
        4.1.1 Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2019-2030)
        4.1.2 Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2019-2030)
        4.1.3 Global Antisense Oligonucleotides (ASO) Drug Average Price by Region (2019-2030)
    4.2 North America Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030)
    4.3 Europe Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030)
    4.4 Asia-Pacific Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030)
    4.5 South America Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030)
    4.6 Middle East and Africa Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2030)
    5.2 Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Type (2019-2030)
    5.3 Global Antisense Oligonucleotides (ASO) Drug Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2030)
    6.2 Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Application (2019-2030)
    6.3 Global Antisense Oligonucleotides (ASO) Drug Average Price by Application (2019-2030)

7 North America
    7.1 North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2030)
    7.2 North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2030)
    7.3 North America Antisense Oligonucleotides (ASO) Drug Market Size by Country
        7.3.1 North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2019-2030)
        7.3.2 North America Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2030)
    8.2 Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2030)
    8.3 Europe Antisense Oligonucleotides (ASO) Drug Market Size by Country
        8.3.1 Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2019-2030)
        8.3.2 Europe Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Antisense Oligonucleotides (ASO) Drug Market Size by Region
        9.3.1 Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2030)
    10.2 South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2030)
    10.3 South America Antisense Oligonucleotides (ASO) Drug Market Size by Country
        10.3.1 South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2019-2030)
        10.3.2 South America Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Market Size by Country
        11.3.1 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Antisense Oligonucleotides (ASO) Drug Market Drivers
    12.2 Antisense Oligonucleotides (ASO) Drug Market Restraints
    12.3 Antisense Oligonucleotides (ASO) Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Antisense Oligonucleotides (ASO) Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Antisense Oligonucleotides (ASO) Drug
    13.3 Antisense Oligonucleotides (ASO) Drug Production Process
    13.4 Antisense Oligonucleotides (ASO) Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Antisense Oligonucleotides (ASO) Drug Typical Distributors
    14.3 Antisense Oligonucleotides (ASO) Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Ionis Basic Information, Manufacturing Base and Competitors
    Table 4. Ionis Major Business
    Table 5. Ionis Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 6. Ionis Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Ionis Recent Developments/Updates
    Table 8. Novartis Basic Information, Manufacturing Base and Competitors
    Table 9. Novartis Major Business
    Table 10. Novartis Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 11. Novartis Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Novartis Recent Developments/Updates
    Table 13. Biogen Basic Information, Manufacturing Base and Competitors
    Table 14. Biogen Major Business
    Table 15. Biogen Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 16. Biogen Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Biogen Recent Developments/Updates
    Table 18. Akcea Basic Information, Manufacturing Base and Competitors
    Table 19. Akcea Major Business
    Table 20. Akcea Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 21. Akcea Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Akcea Recent Developments/Updates
    Table 23. Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 24. Therapeutics Major Business
    Table 25. Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 26. Therapeutics Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Therapeutics Recent Developments/Updates
    Table 28. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 29. Sarepta Therapeutics Major Business
    Table 30. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 31. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Sarepta Therapeutics Recent Developments/Updates
    Table 33. WAVElife Basic Information, Manufacturing Base and Competitors
    Table 34. WAVElife Major Business
    Table 35. WAVElife Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 36. WAVElife Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. WAVElife Recent Developments/Updates
    Table 38. ProQR Basic Information, Manufacturing Base and Competitors
    Table 39. ProQR Major Business
    Table 40. ProQR Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 41. ProQR Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. ProQR Recent Developments/Updates
    Table 43. Exicure Basic Information, Manufacturing Base and Competitors
    Table 44. Exicure Major Business
    Table 45. Exicure Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 46. Exicure Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Exicure Recent Developments/Updates
    Table 48. Secarna Basic Information, Manufacturing Base and Competitors
    Table 49. Secarna Major Business
    Table 50. Secarna Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 51. Secarna Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. Secarna Recent Developments/Updates
    Table 53. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 54. AstraZeneca Major Business
    Table 55. AstraZeneca Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 56. AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 57. AstraZeneca Recent Developments/Updates
    Table 58. The WhiteOak Group, Inc. Basic Information, Manufacturing Base and Competitors
    Table 59. The WhiteOak Group, Inc. Major Business
    Table 60. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 61. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 62. The WhiteOak Group, Inc. Recent Developments/Updates
    Table 63. Dicerna Basic Information, Manufacturing Base and Competitors
    Table 64. Dicerna Major Business
    Table 65. Dicerna Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 66. Dicerna Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 67. Dicerna Recent Developments/Updates
    Table 68. Silence Basic Information, Manufacturing Base and Competitors
    Table 69. Silence Major Business
    Table 70. Silence Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 71. Silence Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 72. Silence Recent Developments/Updates
    Table 73. Arrowhead Basic Information, Manufacturing Base and Competitors
    Table 74. Arrowhead Major Business
    Table 75. Arrowhead Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 76. Arrowhead Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Arrowhead Recent Developments/Updates
    Table 78. Alnylam Basic Information, Manufacturing Base and Competitors
    Table 79. Alnylam Major Business
    Table 80. Alnylam Antisense Oligonucleotides (ASO) Drug Product and Services
    Table 81. Alnylam Antisense Oligonucleotides (ASO) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 82. Alnylam Recent Developments/Updates
    Table 83. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 84. Global Antisense Oligonucleotides (ASO) Drug Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 85. Global Antisense Oligonucleotides (ASO) Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 86. Market Position of Manufacturers in Antisense Oligonucleotides (ASO) Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 87. Head Office and Antisense Oligonucleotides (ASO) Drug Production Site of Key Manufacturer
    Table 88. Antisense Oligonucleotides (ASO) Drug Market: Company Product Type Footprint
    Table 89. Antisense Oligonucleotides (ASO) Drug Market: Company Product Application Footprint
    Table 90. Antisense Oligonucleotides (ASO) Drug New Market Entrants and Barriers to Market Entry
    Table 91. Antisense Oligonucleotides (ASO) Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 92. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 93. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 94. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 95. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 96. Global Antisense Oligonucleotides (ASO) Drug Average Price by Region (2019-2024) & (US$/Unit)
    Table 97. Global Antisense Oligonucleotides (ASO) Drug Average Price by Region (2025-2030) & (US$/Unit)
    Table 98. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 99. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 100. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 101. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 102. Global Antisense Oligonucleotides (ASO) Drug Average Price by Type (2019-2024) & (US$/Unit)
    Table 103. Global Antisense Oligonucleotides (ASO) Drug Average Price by Type (2025-2030) & (US$/Unit)
    Table 104. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 105. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 106. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 107. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 108. Global Antisense Oligonucleotides (ASO) Drug Average Price by Application (2019-2024) & (US$/Unit)
    Table 109. Global Antisense Oligonucleotides (ASO) Drug Average Price by Application (2025-2030) & (US$/Unit)
    Table 110. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 111. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 112. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 113. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 114. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 115. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 116. North America Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 117. North America Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 118. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 119. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 120. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 121. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 122. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 123. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 124. Europe Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 125. Europe Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 126. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 127. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 128. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 129. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 130. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 131. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 132. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 133. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 134. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 135. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 136. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 137. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 138. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2019-2024) & (K Units)
    Table 139. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity by Country (2025-2030) & (K Units)
    Table 140. South America Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 141. South America Antisense Oligonucleotides (ASO) Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 142. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2019-2024) & (K Units)
    Table 143. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Type (2025-2030) & (K Units)
    Table 144. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2019-2024) & (K Units)
    Table 145. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Application (2025-2030) & (K Units)
    Table 146. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2019-2024) & (K Units)
    Table 147. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity by Region (2025-2030) & (K Units)
    Table 148. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 149. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 150. Antisense Oligonucleotides (ASO) Drug Raw Material
    Table 151. Key Manufacturers of Antisense Oligonucleotides (ASO) Drug Raw Materials
    Table 152. Antisense Oligonucleotides (ASO) Drug Typical Distributors
    Table 153. Antisense Oligonucleotides (ASO) Drug Typical Customers
List of Figures
    Figure 1. Antisense Oligonucleotides (ASO) Drug Picture
    Figure 2. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Type in 2023
    Figure 4. Fomivirsen Examples
    Figure 5. Spinraza Examples
    Figure 6. Tegsedi Examples
    Figure 7. Waylivra Examples
    Figure 8. Vyondys 53 Examples
    Figure 9. Global Antisense Oligonucleotides (ASO) Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 10. Global Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Application in 2023
    Figure 11. Single Gene Rare Disease Examples
    Figure 12. Protein Deposition Disease Examples
    Figure 13. Chronic Liver Disease Examples
    Figure 14. Others Examples
    Figure 15. Global Antisense Oligonucleotides (ASO) Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 16. Global Antisense Oligonucleotides (ASO) Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 17. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity (2019-2030) & (K Units)
    Figure 18. Global Antisense Oligonucleotides (ASO) Drug Average Price (2019-2030) & (US$/Unit)
    Figure 19. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Manufacturer in 2023
    Figure 20. Global Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Manufacturer in 2023
    Figure 21. Producer Shipments of Antisense Oligonucleotides (ASO) Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 22. Top 3 Antisense Oligonucleotides (ASO) Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 23. Top 6 Antisense Oligonucleotides (ASO) Drug Manufacturer (Consumption Value) Market Share in 2023
    Figure 24. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 25. Global Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 26. North America Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 27. Europe Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 28. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 29. South America Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 30. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Consumption Value (2019-2030) & (USD Million)
    Figure 31. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 32. Global Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Type (2019-2030)
    Figure 33. Global Antisense Oligonucleotides (ASO) Drug Average Price by Type (2019-2030) & (US$/Unit)
    Figure 34. Global Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 35. Global Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Application (2019-2030)
    Figure 36. Global Antisense Oligonucleotides (ASO) Drug Average Price by Application (2019-2030) & (US$/Unit)
    Figure 37. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 38. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 39. North America Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 40. North America Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 41. United States Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Canada Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 43. Mexico Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 45. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 46. Europe Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 47. Europe Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 48. Germany Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. France Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. United Kingdom Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Russia Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 52. Italy Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 54. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 55. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 56. Asia-Pacific Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 57. China Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Japan Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Korea Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. India Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. Southeast Asia Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 62. Australia Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 64. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 65. South America Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Country (2019-2030)
    Figure 66. South America Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Country (2019-2030)
    Figure 67. Brazil Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 68. Argentina Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Type (2019-2030)
    Figure 70. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Application (2019-2030)
    Figure 71. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Sales Quantity Market Share by Region (2019-2030)
    Figure 72. Middle East & Africa Antisense Oligonucleotides (ASO) Drug Consumption Value Market Share by Region (2019-2030)
    Figure 73. Turkey Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Egypt Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Saudi Arabia Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 76. South Africa Antisense Oligonucleotides (ASO) Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 77. Antisense Oligonucleotides (ASO) Drug Market Drivers
    Figure 78. Antisense Oligonucleotides (ASO) Drug Market Restraints
    Figure 79. Antisense Oligonucleotides (ASO) Drug Market Trends
    Figure 80. Porters Five Forces Analysis
    Figure 81. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASO) Drug in 2023
    Figure 82. Manufacturing Process Analysis of Antisense Oligonucleotides (ASO) Drug
    Figure 83. Antisense Oligonucleotides (ASO) Drug Industrial Chain
    Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 85. Direct Channel Pros & Cons
    Figure 86. Indirect Channel Pros & Cons
    Figure 87. Methodology
    Figure 88. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Alnylam

Related Reports

Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2023-2029

Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2023-2029

date 02 Sep 2023

date Pharma & Healthcare

The global Antisense Oligonucleotides (ASO) Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Antisense Oligonucleotides (ASO) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Antisense Oligonucleotides (ASO) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 02 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Antisense Oligonucleotides (ASO) Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2024-2030

Global Antisense Oligonucleotides (ASO) Drug Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

The global Antisense Oligonucleotides (ASO) Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Antisense oligonucleotides (ASO) Drug and siRNA Drug

Antisense Oligonucleotides (ASO) Drug

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>